| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Jeffrey L. Ives is Director at TVRD and has filed Form 4s across 2 companies. From June 2019 to June 2026, the filings on record show 0 open-market purchases and 16 sales. Jeffrey L. Ives's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $177K at current prices.
Historically, Jeffrey L. Ives's trades have earned a middling insider score of 68/100 across 4 rated trades. Over a 12-month horizon, all 4 of those trades were profitable, with an average 12-month return of +48.7%.
The biggest single holding is TVRD (~$166K) as Director. The TVRD filings lean toward selling, a net 42,800 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2019 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $25.83 | $64,575.00 | -29.4% | |
| Nov 1, 2019 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $20.68 | $51,700.00 | -29.4% | |
| Oct 1, 2019 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $18.21 | $45,525.00 | -29.4% | |
| Sep 3, 2019 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $23.31 | $58,275.00 | -29.4% | |
| Aug 1, 2019 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $23.24 | $58,100.00 | -29.4% | |
| Jul 1, 2019 | TVRD Tvardi Therapeutics, Inc. | Director | Sale+OE | 2,500 | $21.75 | $54,375.00 | -29.4% |